Skip to main content
Market Entry Sprint — reviewed package in 10 business days · from $2,500 · 35+ countries of intelligence.See pricing
GH
Documentation

Documentation

Guides for getting started with GHMAP, understanding the platform, finding audience-specific paths, reading data methodology, and checking API status. Content here supports planning and review — it is not clinical, legal, regulatory, or investment advice.

Important notice

GHMAP documentation describes how the platform organizes healthcare market-access intelligence. It does not provide diagnosis, treatment advice, legal advice, regulatory approval, reimbursement guarantees, investment advice, or market-entry guarantees. Professional review is required before business use. Do not submit patient data, medical records, passwords, bank information, or confidential contracts through public pages.

Documentation sections

Each section points to existing GHMAP pages and honest status language. Where a capability is not published yet — such as a public API — it is marked Coming soon.

Getting Started

Start with the public pages that explain how GHMAP structures market-access work before you open a project.

  • Use the sample brief to see how source status, evidence gaps, review needs, and next actions appear in a GHMAP country comparison.
  • The resource center covers source-status language, glossary terms, and how to read a brief before you rely on any field.
  • When you are ready for a reviewed package, start a project so a human review path can be scoped to your product and target markets.
View the sample brief →Browse the resource center →Start a project →

Platform Overview

GHMAP organizes healthcare market-access questions across countries, products, certifications, and review workflows.

  • Public tools and workspace pages keep source status visible so teams can separate verified inputs from placeholders and open questions.
  • Country intelligence, certification pathways, readiness checks, and project workflows are designed to support planning — not to replace qualified professionals.
  • Public website behavior on ghmap.io stays separate from authenticated workspace behavior on app.ghmap.io.
Explore the platform →Open country intelligence →Browse certification pathways →

For Each Audience

GHMAP serves manufacturers, clinicians, distributors, hospitals, investors, and operators with role-specific market-access planning paths.

  • Manufacturers
  • Doctors & KOLs
  • Distributors
  • Hospitals
  • Investors
  • Operators & Consultants
  • Manufacturers structure product-country questions, certification context, and launch-readiness needs before committing resources.
  • Doctors and KOLs contribute clinical and local-market review context where professional input is required.
  • Distributors and importers organize partner-readiness, documentation, and market-entry dependencies.
  • Hospitals and clinics evaluate vendor and introduction context with source and review status kept visible.
  • Investors and advisors compare evidence gaps, pathway questions, and review needs across target markets.
  • Operators and consultants coordinate multi-stakeholder workflows without treating GHMAP as a substitute for specialist advice.
Manufacturers →Doctors & KOLs →Distributors →Hospitals →Investors →Operators & consultants →

Data & Methodology

Every market-access field should carry source context, confidence language, and a clear review boundary.

  • GHMAP methodology distinguishes source type, jurisdiction, source date, review date, and confidence level where those fields are recorded.
  • Labels such as Source required, To be verified, Reviewed, Outdated, and Example only are planning signals — not regulatory or reimbursement conclusions.
  • Professional review remains required before market-access content is used for business decisions.
Read the methodology →See trust and review standards →Open the glossary →

API

Coming soon

A public developer API is not published yet. Coming soon — do not assume endpoints, authentication schemes, or rate limits.

  • GHMAP does not currently publish public API reference documentation or stable endpoint contracts.
  • If your team needs machine-readable market-access exports or integrations, describe the use case when you start a project so it can be reviewed against current platform capabilities.
  • Until public API docs ship, treat any third-party or speculative endpoint lists as unverified.
Ask about API access needs →

Ready to begin?

Start a project to scope product, countries, open questions, and review needs. Related public pages remain available for methodology, trust, and sample brief context.

Book a Market Entry SprintView sample brief →Methodology →